Clinical trial
Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy
NCT01525888 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy
- Lead sponsor
- Soroka University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- December 31, 2013
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
radiographic contrast agent nephropathy